These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
521 related articles for article (PubMed ID: 8639560)
21. Palmitylation of Src family tyrosine kinases regulates functional interaction with a B cell substrate. Saouaf SJ; Wolven A; Resh MD; Bolen JB Biochem Biophys Res Commun; 1997 May; 234(2):325-9. PubMed ID: 9177269 [TBL] [Abstract][Full Text] [Related]
22. Crystal structures of the human p56lck SH2 domain in complex with two short phosphotyrosyl peptides at 1.0 A and 1.8 A resolution. Tong L; Warren TC; King J; Betageri R; Rose J; Jakes S J Mol Biol; 1996 Mar; 256(3):601-10. PubMed ID: 8604142 [TBL] [Abstract][Full Text] [Related]
23. Structural basis for activation of human lymphocyte kinase Lck upon tyrosine phosphorylation. Yamaguchi H; Hendrickson WA Nature; 1996 Dec; 384(6608):484-9. PubMed ID: 8945479 [TBL] [Abstract][Full Text] [Related]
24. The SH2 domain from the tyrosine kinase Fyn in complex with a phosphotyrosyl peptide reveals insights into domain stability and binding specificity. Mulhern TD; Shaw GL; Morton CJ; Day AJ; Campbell ID Structure; 1997 Oct; 5(10):1313-23. PubMed ID: 9351806 [TBL] [Abstract][Full Text] [Related]
25. Three-dimensional structure of the human immunodeficiency virus type 1 matrix protein. Massiah MA; Starich MR; Paschall C; Summers MF; Christensen AM; Sundquist WI J Mol Biol; 1994 Nov; 244(2):198-223. PubMed ID: 7966331 [TBL] [Abstract][Full Text] [Related]
26. Solution structure and backbone dynamics of the human alpha3-chain type VI collagen C-terminal Kunitz domain, Sorensen MD; Bjorn S; Norris K; Olsen O; Petersen L; James TL; Led JJ Biochemistry; 1997 Aug; 36(34):10439-50. PubMed ID: 9265624 [TBL] [Abstract][Full Text] [Related]
27. The 2.35 A crystal structure of the inactivated form of chicken Src: a dynamic molecule with multiple regulatory interactions. Williams JC; Weijland A; Gonfloni S; Thompson A; Courtneidge SA; Superti-Furga G; Wierenga RK J Mol Biol; 1997 Dec; 274(5):757-75. PubMed ID: 9405157 [TBL] [Abstract][Full Text] [Related]
28. Signalling by the p60c-src family of protein-tyrosine kinases. Kefalas P; Brown TR; Brickell PM Int J Biochem Cell Biol; 1995 Jun; 27(6):551-63. PubMed ID: 7545532 [TBL] [Abstract][Full Text] [Related]
29. The structure of the membrane distal phosphatase domain of RPTPalpha reveals interdomain flexibility and an SH2 domain interaction region. Sonnenburg ED; Bilwes A; Hunter T; Noel JP Biochemistry; 2003 Jul; 42(26):7904-14. PubMed ID: 12834342 [TBL] [Abstract][Full Text] [Related]
30. Crystal structure of the SH2 domain from the adaptor protein SHC: a model for peptide binding based on X-ray and NMR data. Mikol V; Baumann G; Zurini MG; Hommel U J Mol Biol; 1995 Nov; 254(1):86-95. PubMed ID: 7473762 [TBL] [Abstract][Full Text] [Related]
31. Correlation of the phosphorylation states of pp60c-src with tyrosine kinase activity: the intramolecular pY530-SH2 complex retains significant activity if Y419 is phosphorylated. Boerner RJ; Kassel DB; Barker SC; Ellis B; DeLacy P; Knight WB Biochemistry; 1996 Jul; 35(29):9519-25. PubMed ID: 8755732 [TBL] [Abstract][Full Text] [Related]
32. The crystal structures of the SH2 domain of p56lck complexed with two phosphonopeptides suggest a gated peptide binding site. Mikol V; Baumann G; Keller TH; Manning U; Zurini MG J Mol Biol; 1995 Feb; 246(2):344-55. PubMed ID: 7532720 [TBL] [Abstract][Full Text] [Related]
33. Determination of affinities for lck SH2 binding peptides using a sensitive fluorescence assay: comparison between the pYEEIP and pYQPQP consensus sequences reveals context-dependent binding specificity. Cousins-Wasti RC; Ingraham RH; Morelock MM; Grygon CA Biochemistry; 1996 Dec; 35(51):16746-52. PubMed ID: 8988011 [TBL] [Abstract][Full Text] [Related]
34. Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide. Xu RX; Word JM; Davis DG; Rink MJ; Willard DH; Gampe RT Biochemistry; 1995 Feb; 34(7):2107-21. PubMed ID: 7532003 [TBL] [Abstract][Full Text] [Related]
35. Interactions between the Fyn SH3-domain and adaptor protein Cbp/PAG derived ligands, effects on kinase activity and affinity. Solheim SA; Petsalaki E; Stokka AJ; Russell RB; Taskén K; Berge T FEBS J; 2008 Oct; 275(19):4863-74. PubMed ID: 18721137 [TBL] [Abstract][Full Text] [Related]
36. Crystal structure of the C-terminal SH2 domain of the p85alpha regulatory subunit of phosphoinositide 3-kinase: an SH2 domain mimicking its own substrate. Hoedemaeker FJ; Siegal G; Roe SM; Driscoll PC; Abrahams JP J Mol Biol; 1999 Oct; 292(4):763-70. PubMed ID: 10525402 [TBL] [Abstract][Full Text] [Related]
37. Binding affinity difference induced by the stereochemistry of the sulfoxide bridge of the cyclic peptide inhibitors of Grb2-SH2 domain: NMR studies for the structural origin. Shi YH; Song YL; Lin DH; Tan J; Roller PP; Li Q; Long YQ; Song GQ Biochem Biophys Res Commun; 2005 May; 330(4):1254-61. PubMed ID: 15823578 [TBL] [Abstract][Full Text] [Related]
38. Hydrophobic interaction between the SH2 domain and the kinase domain is required for the activation of Csk. Mikkola ET; Gahmberg CG J Mol Biol; 2010 Jun; 399(4):618-27. PubMed ID: 20434462 [TBL] [Abstract][Full Text] [Related]
39. Molecular cloning and chromosomal localization of the human homologue of a B-lymphocyte specific protein tyrosine kinase (blk). Drebin JA; Hartzell SW; Griffin C; Campbell MJ; Niederhuber JE Oncogene; 1995 Feb; 10(3):477-86. PubMed ID: 7845672 [TBL] [Abstract][Full Text] [Related]
40. Structure and ligand recognition of the phosphotyrosine binding domain of Shc. Zhou MM; Ravichandran KS; Olejniczak EF; Petros AM; Meadows RP; Sattler M; Harlan JE; Wade WS; Burakoff SJ; Fesik SW Nature; 1995 Dec; 378(6557):584-92. PubMed ID: 8524391 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]